Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Common-Size Income Statement

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Medtronic PLC, common-size consolidated income statement

Microsoft Excel
12 months ended: Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020 Apr 26, 2019
Net sales
Cost of products sold, excluding amortization of intangible assets
Gross profit
Research and development expense
Selling, general, and administrative expense
Amortization of intangible assets
Restructuring charges, net
Certain litigation charges, net
Other operating income (expense), net
Operating profit
Other non-operating income, net
Interest expense, net
Income before income taxes
Income tax (provision) benefit
Net income
Net income attributable to noncontrolling interests
Net income attributable to Medtronic

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).

Income statement item Description The company
Operating profit The net result for the period of deducting operating expenses from operating revenues. Medtronic PLC operating profit as a percentage of net sales decreased from 2022 to 2023 and from 2023 to 2024.
Income before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Medtronic PLC income before income taxes as a percentage of net sales decreased from 2022 to 2023 and from 2023 to 2024.
Net income attributable to Medtronic The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Medtronic PLC net income attributable to Medtronic as a percentage of net sales decreased from 2022 to 2023 and from 2023 to 2024.